Hospital-acquired Infection Control Market

Hospital-acquired Infection Control Market 2023 to 2033

Newly-released Hospital-acquired Infection Control Market analysis report by Future Market Insights shows that global sales of Hospital-acquired Infection Control in 2023 were held at USD 6.5 Billion. With a CAGR of 7% from 2023 to 2033, the market is projected to reach USD 12.7 Billion by 2033. The market is expected to generate significant revenue through Hospitals and Intensive care Units, accounting for a CAGR of 7.6%.

Attribute	Details
Global Hospital-Acquired Infection Control Market (2023)	USD 6.5 Billion
Global Hospital-Acquired Infection Control Market (2033)	USD 12.7 Billion
Global Hospital-Acquired Infection Control Market CAGR (2023 to 2033)	7%
USA Hospital-Acquired Infection Control Market CAGR (2023 to 2033)	8.1%
Key Companies Profiled	Steris Plc; Sotera Health Company; Getinge AB; Advanced Sterilization Products; Ecolab Inc.; 3M Company; Matachana Group; MMM Group; Belimed AG; Reckitt Benckiser

Revenue of Hospital-acquired Infection Control from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the Hospital-acquired Infection Control industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Hospital-acquired Infection Control market increased at a CAGR of 6.5%, wherein, countries such as the USA, the United kingdom, China, South Korea and Japan held significant share in the global market. Owing to this, the market is projected to grow at a CAGR of 7.6% over the coming 10 years.

Which factors are leading to growth of the Hospital-acquired Infection Control industry?

The frequent occurrence of hospital-acquired infections, the growing proportion of surgical procedures, the rising geriatric population and the increasing prevalence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental and personal hygiene are the key factors driving the growth of the Hospital-acquired infection control market.

The growing use of e-beam sterilization and the reintroduction of ethylene oxide sterilization are further expected to swell the demand for hospital-acquired infection control.

The percentage of surgeries performed worldwide has increased significantly over the years. Every year, approximately 235 million complex surgical procedures are performed worldwide, according to the WHO. This is due to an increase in the prevalence of obesity and other lifestyle diseases, an increase in the geriatric population, and an increase in the incidence of spinal injuries and sports-related injuries.

With the growth in the number of surgical procedures conducted, the demand for various surgical equipment and medical devices is also surging. The proven benefits of sterilized product lines and growing awareness about their effectiveness in healthcare settings are expected to drive demand for hospital-acquired infection services.

Ethylene oxide is one of the most effective gaseous sterilizing agents for high-temperature-sensitive instruments, such as plastic equipment and instruments with electrical components. The CDC, on the other hand, has stated that chronic exposure to ethylene oxide in the workplace can cause cancer. Furthermore, ethylene oxide sterilization can irritate the skin and mucous membranes, causing CNS abnormalities in humans.

Acute exposure to EtO gas, on the other hand, can cause respiratory irritation, lung injury, headache, nausea, vomiting, diarrhea, shortness of breath, and cyanosis. EtO degrades in the atmosphere as well, reacting with photochemically generated hydroxyl radicals. Regulatory frameworks have been established in several countries to govern the use of EtO in specific sterilization applications.

Region-wise Analysis

Which Region is projected to Offer Significant Opportunity for Hospital-acquired Infection Control?

Due to rising demand for Hospital-acquired Infection Control methods in developing nations, particularly Japan, the market in the Asia Pacific is projected to account for a CAGR of over 7% during the forecast period.

The regional market is growing due to the extensive usage of Hospital-acquired infection controls and increased awareness of general health and fitness among the working-class population.

Country-wise Analysis

USA Hospital-acquired Infection Control Market Analysis

The USA stands as one of the largest markets for hospital-acquired infection control. The market growth in the region is characterized by rising demand for and adoption of sterilization and disinfection products and services as a result of consumers' increased emphasis on healthy lifestyles and disease prevention.

The increase in the geriatric population in the coming years, as well as the subsequent rise in the incidence of chronic diseases, the need for Hospital-acquired infection control to reduce the prevalence of HAIs, and the implementation of favorable government initiatives and stringent sterilization and disinfection regulations, are driving the Hospital-acquired infection market in the country.

United kingdom Hospital-acquired Infection Control Market Analysis

The market in the United kingdom is expected to reach a valuation of USD 527 Million by 2033. Growing with a CAGR of 5.8% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around USD 227.7 Million.

Japan Hospital-acquired Infection Control Market Analysis

In Japan, the market is expected to grow at a CAGR of 6.8% from 2023 to 2033, reaching around USD 490.6 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of USD 238 Million during the forecast period.

South Korea Hospital-acquired Infection Control Market Analysis

The market in South Korea is expected to reach a valuation of around USD 262 Million by 2033, growing at a CAGR of 6.6% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around USD 123.7 Million.

Category-wise Insights

Why do Ambulatory Surgical and Diagnostic Centers account for a Significant Proportion of Hospital-acquired Infection Control Market Revenue?

Hospitals and intensive care units, ambulatory surgical & diagnostic centers, nursing homes, and maternity centers, as well as other end users, make up the Hospital-acquired infection control market. The market revenue through the ambulatory surgery and diagnostic centers category is predicted to increase at a significant CAGR throughout the projection period.

The large contribution to the market revenue through ambulatory surgical and diagnostic centers is due to the rising prevalence of HAIs, and increasing acceptance of single-use medical devices in these healthcare facilities.

Competitive Analysis

The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.

Some of the recent developments of key Hospital-acquired Infection Control providers are as follows:

• In 2021, STERIS purchased Cantel, a global provider of infection control products and services, through a USA subsidiary to broaden its vast array of sterilization services.
• In 2021, Sterigenics S.A.S., a Sotera Health Company subsidiary, increased its European sterilizing capacity by expanding its ethylene oxide factory in Rantigny, France. Getinge introduced the Getinge Solsus 66 steam sterilizer for hospitals as well as surgical instruments in 2020, which has a higher capacity and operational reliability than other sterilizers.
• In 2020, Sotera Health Company acquired Iotron, a prominent North American outsourced provider of E-beam sterilization services. The acquisition was intended to help the company expand its electron beam footprint and boost sales of the Sterigenics division.
• In 2020, Key Surgical was acquired by STERIS. This acquisition increased the company's product offering and revenue by 35%.

Similarly, recent developments related to companies offering Hospital-acquired Infection Control have been tracked by the team at Future Market Insights, which is available in the full report.

Market Segments Covered in Hospital-acquired Infection Control Industry Analysis

By Component:

• Equipment
  • Sterilization Equipment
  • Disinfection Equipment
• Consumables
  • Disinfectants
  • Sterilization Consumables
  • Others (Waste Disposal, PPE)
• Services

By End-user:

• Hospitals and Intensive Care Units
• Ambulatory Surgical and Diagnostic Centers
• Other End-users

Frequently Asked Questions

How Much Is the Market Currently Worth?

Market analysts predict that by 2023 it may be worth USD 6.5 billion.

How Has the Market Performed in the Past?

Sales soared considerably at an HCAGR of 6.5% from 2018 to 2022.

What is the CAGR of the Market?

Through 2033, the market is projected to maintain its momentum at a CAGR of 7%.

Which Size Is the Market Envisioned to Be In 2033?

By 2033, it is expected that the size of the global market will approach USD 12.7 billion.

What Is the Market CAGR of The Asia Pacific?

The Asia Pacific market is scheduled to expand at a CAGR of 7% through 2033.

What Is the Growth Outlook of the United Kingdom Market?

United Kingdom’s market is poised to develop at a CAGR of 5.8% through 2033.